Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with ...
Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...
Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...
In 2022, the WHO hailed Novartis’ GanLum as the most promising non-artemisinin-based combination. The Swiss drugmaker ...
A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug ...
Novartis said its experimental treatment cured more than 99% of malaria cases in the trial, marking a big step toward ...
The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...
News Medical on MSN
Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial
Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...
Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...
A fungal infection solution could help eliminate up to 86% of malaria-carrying mosquitoes, offering a powerful new tool in ...
Scientists have created the first new anti- malaria drug in a quarter of a century to combat resistance to existing ...
Amid global health cuts, the UK’s commitment to health funding has diminished.The UK said it will invest £850 million in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback